Neuromed IRCCS
87
13
15
22
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
6.9%
6 terminated/withdrawn out of 87 trials
78.6%
-7.9% vs industry average
2%
2 trials in Phase 3/4
9%
2 of 22 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (87)
Italian Validation of the Dynamic Neurocognitive Adaptation (dNA) Scale and Its Correlation With Neurocognitive Variables
Role: lead
Remote Monitoring to Prevent Frailty Progression in the Elderly
Role: lead
Mediterranean Diet on Pregnancy and Foetus Development
Role: lead
Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)
Role: collaborator
Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease.
Role: lead
Transcranial Static Magnetic Stimulation (tSMS) in Huntington's Disease (HD)
Role: lead
Exercise Therapy in Multiple Sclerosis
Role: collaborator
Italian Digital Primary Cardiovascular Prevention Study
Role: collaborator
Effect of Anodal Transcranial Direct Current Stimulation on Postdural Puncture Headache
Role: lead
Transcranial Static Field Stimulation (tSMS) and Transcranial Direct Current Stimulation (tDCS) for the Treatment of Neurological Symptoms.
Role: lead
Three miRNA Signatures in Glioma: From Molecular Mechanisms to Potential Clinical Application
Role: collaborator
Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders
Role: lead
Psychometric Evaluation in Patients With Brain Damage During Neuroinflammation
Role: lead
Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis
Role: lead
Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)
Role: collaborator
miR-142-3p as Potential Biomarker of Synaptopathy in MS
Role: lead
Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)
Role: lead
Integrated Treatment in FND (Functional Neurological Disorders)
Role: lead
Parkinson's Disease and Gamma-transcranial Alternating Current Stimulation
Role: lead
Effectiveness of Multimodal Physical Therapy in Migraine
Role: lead